Quad Asset Management logo

Quad Asset Management

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Quad Asset Management is an Investment firm.

Investor Profile

Quad Asset Management has backed more than 8 startups, with 4 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in South Korea, United States.
  • Strong thematic focus on Biotechnology, Artificial Intelligence (AI), Medical.

Stage Focus

  • Series A (38%)
  • Series C (25%)
  • Series B (25%)
  • Series Unknown (13%)

Country Focus

  • South Korea (88%)
  • United States (13%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Medical
  • Software
  • Pharmaceutical
  • Machine Learning
  • Neuroscience
  • Biopharma
  • Robotics
  • Online Portals
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Quad Asset Management frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Kolon Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
DB Financial Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KB Securities
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Solidus Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Mirae Asset Securities
North America, New York, United States, Nyack
Co-Investments: 1
Prophet Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Premier Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
K2 Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2

Which angels does Quad Asset Management often collaborate with?

SK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Quad Asset Management?

Illimis Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series BJul 14, 2025
Amount Raised: $42,004,389
Prazer Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 1, 2025
Amount Raised: $19,728,977
Ubix Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

BiotechnologyMedical
Series CDec 23, 2024
Amount Raised: $17,716,685
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
Cubixel

Seoul, Seoul-t'ukpyolsi, South Korea

Cubixel develops and commercializes optical inspection equipment for the medical and bio industry.

BiotechnologyMedical
Series UnknownSep 6, 2024
Amount Raised: $12,698,223
NEUROPHET

Gangneung, Kangwon-do, South Korea

NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.

Artificial Intelligence (AI)Machine LearningMedicalNeuroscienceSoftware
Series CNov 7, 2023
Amount Raised: $15,325,964
Creatz

Suwon, Ch'ungch'ong-namdo, South Korea

Creatz is a sports consulting online platform based on artificially generated data.

Artificial Intelligence (AI)Online PortalsSports
Series ADec 8, 2021
Amount Raised: $21,319,234
AKA

Santa Monica, California, United States

AKA is the invincible Generative AI company: to create revolutionary and life-saving AI product

Artificial Intelligence (AI)RoboticsSoftware
Series BJan 8, 2021
Amount Raised: $17,383,190
Rznomics

Gwangju, Kwangju-jikhalsi, South Korea

Rznomics is a biotechnology company.

BiopharmaBiotechnology
Series AOct 30, 2019
Amount Raised: $10,303,083